Brief: Volitionrx Ltd Posts Q3 Net Loss Of $7.2 Million
10/11/2021 23:13
Nov 10 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LTD - NET LOSS FOR Q3 OF 2021 WAS $7.2 MILLION
VERSUS
$5.6 MILLION PRIOR QUARTER WITH INCREASE PRIMARILY DUE TO
NON-CASH ITEMS
Source text for Eikon: ID:nPn2hM3NXa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems